ArticleRSC advances2026

Correction: Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting.

Marwa N Rahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.